Boston Scientific (BSX) Current Assets (2009 - 2026)

Boston Scientific (BSX) has 18 years of Current Assets data on file, last reported at $8.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 18.39% year-over-year to $8.7 billion; the trailing twelve-month figure through Mar 2026 stood at $8.7 billion (up 18.39% YoY), and the FY2025 full-year result was $8.8 billion, up 27.08% from the prior year.
• Current Assets fell to $8.7 billion in Q1 2026, from $8.8 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $9.0 billion in Q2 2024 to a low of $5.1 billion in Q1 2022.
• A 5-year average of $7.0 billion and a median of $6.9 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets decreased 24.79% in 2022 and jumped 52.75% in 2024, its largest moves.
• Tracing BSX's Current Assets over 5 years: stood at $5.8 billion in 2022, then grew by 13.09% to $6.5 billion in 2023, then advanced by 6.23% to $6.9 billion in 2024, then advanced by 27.08% to $8.8 billion in 2025, then fell by 1.25% to $8.7 billion in 2026.
• Business Quant data shows BSX's Current Assets at $8.7 billion in Q1 2026, $8.8 billion in Q4 2025, and $8.0 billion in Q3 2025.